Pre-op Chemo-RT w/CDDP/5FU vs Chemo w/ Docetaxel/Irinotecan in PET Non Responder Resectable Esophagus Cancer

Carcinoma of Esophagus Clinical Trial

Official title:
A Trial Comparing Pre-operative Chemo-radiotherapy With Cisplatin and Fluorouracil Versus Chemotherapy With Docetaxel and Irinotecan in PET Non Responders Resectable Cancer Esophagus: a Multicenter Study

Status Terminated

Clinical Trial Summary

The purpose of this study is to improve their outcome by either changing the chemotherapy drugs or giving them radiation therapy with concurrent chemotherapy, hoping that this will improve their outcome.

Clinical Trial Description

This study is aimed at improving the outcome of resectable non PET responders, esophageal carcinoma, by either changing the chemotherapy drugs or giving them radiation therapy with concurrent chemotherapy, hoping that this will improve their outcome. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01608464
Study type	Interventional
Source	King Faisal Specialist Hospital & Research Center
Contact
Status	Terminated
Phase	Phase 2
Start date	May 2012
Completion date	September 2015

View Details

See also
	Status	Clinical Trial	Phase
	Not yet recruiting	`NCT04985357` - Defining the Clinical Potential of Mass Response as a Biomarker for Patient Tumor Sensitivity to Drugs
	Recruiting	`NCT05461430` - Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)